Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1973
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 4
1975 3
1976 1
1977 2
1978 1
1980 2
1981 2
1982 1
1987 1
1988 1
1989 1
2008 2
2009 1
2010 3
2011 4
2012 1
2013 2
2017 2
2018 1
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P. Kendler DL, et al. Among authors: moricke r. Lancet. 2018 Jan 20;391(10117):230-240. doi: 10.1016/S0140-6736(17)32137-2. Epub 2017 Nov 9. Lancet. 2018. PMID: 29129436 Clinical Trial.
[Zieve's syndrome].
Möricke R. Möricke R. Z Gesamte Inn Med. 1973 Jan 1;28(1):21-4. Z Gesamte Inn Med. 1973. PMID: 4694332 German. No abstract available.
Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial.
Body JJ, Marin F, Kendler DL, Zerbini CAF, López-Romero P, Möricke R, Casado E, Fahrleitner-Pammer A, Stepan JJ, Lespessailles E, Minisola S, Geusens P. Body JJ, et al. Among authors: moricke r. Osteoporos Int. 2020 Oct;31(10):1935-1942. doi: 10.1007/s00198-020-05463-4. Epub 2020 May 30. Osteoporos Int. 2020. PMID: 32474650 Free PMC article.
[Complications of cardiac pacemakers].
Möricke R, Trenckmann H. Möricke R, et al. Z Gesamte Inn Med. 1975 Sep 15;30(18):595-603. Z Gesamte Inn Med. 1975. PMID: 1216939 German.
Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial.
Glüer CC, Marin F, Ringe JD, Hawkins F, Möricke R, Papaioannu N, Farahmand P, Minisola S, Martínez G, Nolla JM, Niedhart C, Guañabens N, Nuti R, Martín-Mola E, Thomasius F, Kapetanos G, Peña J, Graeff C, Petto H, Sanz B, Reisinger A, Zysset PK. Glüer CC, et al. Among authors: moricke r. J Bone Miner Res. 2013 Jun;28(6):1355-68. doi: 10.1002/jbmr.1870. J Bone Miner Res. 2013. PMID: 23322362 Free PMC article. Clinical Trial.
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis.
Farahmand P, Marin F, Hawkins F, Möricke R, Ringe JD, Glüer CC, Papaioannou N, Minisola S, Martínez G, Nolla JM, Niedhart C, Guañabens N, Nuti R, Martín-Mola E, Thomasius F, Peña J, Graeff C, Kapetanos G, Petto H, Gentzel A, Reisinger A, Zysset PK. Farahmand P, et al. Among authors: moricke r. Osteoporos Int. 2013 Dec;24(12):2971-81. doi: 10.1007/s00198-013-2379-5. Epub 2013 Jun 6. Osteoporos Int. 2013. PMID: 23740422 Free PMC article. Clinical Trial.
Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass.
Hadji P, Gamerdinger D, Spieler W, Kann PH, Loeffler H, Articus K, Möricke R, Ziller V. Hadji P, et al. Among authors: moricke r. Osteoporos Int. 2012 Feb;23(2):625-33. doi: 10.1007/s00198-011-1583-4. Epub 2011 Mar 26. Osteoporos Int. 2012. PMID: 21442459 Clinical Trial.
33 results